CR20120465A - IMPROVED FORMULATIONS FOR ACTIVE PHARMACEUTICAL INGREDIENTS OF DEFICIENT PERMEABILITY - Google Patents

IMPROVED FORMULATIONS FOR ACTIVE PHARMACEUTICAL INGREDIENTS OF DEFICIENT PERMEABILITY

Info

Publication number
CR20120465A
CR20120465A CR20120465A CR20120465A CR20120465A CR 20120465 A CR20120465 A CR 20120465A CR 20120465 A CR20120465 A CR 20120465A CR 20120465 A CR20120465 A CR 20120465A CR 20120465 A CR20120465 A CR 20120465A
Authority
CR
Costa Rica
Prior art keywords
permeability
active pharmaceutical
deficient
pharmaceutical ingredients
improved formulations
Prior art date
Application number
CR20120465A
Other languages
Spanish (es)
Inventor
Jan P Moschwitzer
Aldo Ket
Heike Dinter-Heidorn
Original Assignee
Abbott Products Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Products Gmbh filed Critical Abbott Products Gmbh
Priority to CR20120465A priority Critical patent/CR20120465A/en
Publication of CR20120465A publication Critical patent/CR20120465A/en

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

La presente invención se relaciona con una dosificación oral farmacéutica que contiene un ingrediente farmacéutico activo de permeabilidad deficiente y al menos una sustancia mejoradora de permeabilidad.The present invention relates to an oral pharmaceutical dosage containing an active pharmaceutical ingredient of poor permeability and at least one permeability enhancing substance.

CR20120465A 2012-09-13 2012-09-13 IMPROVED FORMULATIONS FOR ACTIVE PHARMACEUTICAL INGREDIENTS OF DEFICIENT PERMEABILITY CR20120465A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CR20120465A CR20120465A (en) 2012-09-13 2012-09-13 IMPROVED FORMULATIONS FOR ACTIVE PHARMACEUTICAL INGREDIENTS OF DEFICIENT PERMEABILITY

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CR20120465A CR20120465A (en) 2012-09-13 2012-09-13 IMPROVED FORMULATIONS FOR ACTIVE PHARMACEUTICAL INGREDIENTS OF DEFICIENT PERMEABILITY

Publications (1)

Publication Number Publication Date
CR20120465A true CR20120465A (en) 2012-11-02

Family

ID=47290218

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20120465A CR20120465A (en) 2012-09-13 2012-09-13 IMPROVED FORMULATIONS FOR ACTIVE PHARMACEUTICAL INGREDIENTS OF DEFICIENT PERMEABILITY

Country Status (1)

Country Link
CR (1) CR20120465A (en)

Similar Documents

Publication Publication Date Title
CY1122786T1 (en) DOSAGE FORMS FOR Echinocandin Class Compounds
MX2021000550A (en) Tofacitinib oral sustained release dosage forms.
EP2958913A4 (en) SPHINOSIN-1-PHOSPHATE RECEPTOR AGONISTS, METHODS OF PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AS ACTIVE INGREDIENT
EA201590805A1 (en) COMPOSITION WITH IMMEDIATE AND PROLONGED DELIVERY
EA201591166A1 (en) AUTOTAXIN INHIBITORS
CR20140365A (en) CARBAMATE COMPOUNDS AND PREPARATION AND USE OF THE SAME
EA201270741A1 (en) ORAL COMPOSITIONS AND LIPOPHYL SALTS OF METHylNALTREX
EP2832851A4 (en) IMMORTALIZED STEM CELLS AND MEDICINAL COMPOSITION AND MEDICINAL PREPARATION COMPRISING AN ASSOCIATED PRODUCT AS ACTIVE INGREDIENT
HRP20181607T1 (en) STABLE ORAL SOLUTIONS FOR COMBINED ACTIVE PHARMACEUTICAL INGREDIENTS
PL3003285T3 (en) Solid pharmaceutical dosage form for release of at least two active pharmaceutical ingredients in the oral cavity
EA201291211A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING HYDROMORPHONE AND NALOXONE
MX344846B (en) COMBINATION OF ACTIVE LOADED GRANULES WITH ADDITIONAL ASSETS.
UA110979C2 (en) Liquid pharmaceutical formulation comprising nitisinone
BR112015027436A2 (en) Topical composition and carrier for administration of pharmaceutically or cosmetically active ingredients
MX2016001422A (en) Pharmaceutical compositions of fingolimod.
MX357704B (en) O/w-emulsion-type topical pharmaceutical compositions containing a retinoid.
HUE050945T2 (en) Dosage form for sustained release of active ingredients
EA201400444A1 (en) DERIVATIVES 2-OXOPYPERIDINYL
UY34080A (en) PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION THAT INCLUDES FEXOFENADINE AND PREPARATION METHODS
TR200909785A1 (en) Pharmaceutical compositions containing cefdinir as the active agent.
MX2017013633A (en) Tamper-resistant fixed dose combination providing fast release of two drugs from particles.
EA201291420A1 (en) ORAL MEDICAL FORMS CONTAINING LERCANIDIPIN AND ENALAPRIL AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS
TR201010859A2 (en) Tablet forms containing cefdinir.
GB201216893D0 (en) Drug substance preparations, pharmaceutical compositions and dosage forms comprising s-(+)-flurbiprofen
EA201491477A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING FLUPIRTIN